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Introduction: The aim of this study is to examine the
effects of an internet-based cognitive behavioural
therapy (iCBT) program on decreasing the risk of major
depressive episodes (MDEs) among workers employed
in a private corporate group in Japan, using a
randomised controlled trial design.
Methods and analysis: All of the workers in a
corporate group (n=20 000) will be recruited through
an invitation email. Participants who fulfil the inclusion
criteria will be randomly allocated to intervention or
control groups (planned N=4050 for each group). They
will be allowed to complete the six lessons of the iCBT
program within 10 weeks after the baseline survey.
Those in the control group will receive the same iCBT
after 12 months. The program includes several CBT
skills: self-monitoring, cognitive restructuring,
assertiveness, problem-solving and relaxation. The
primary outcome measure is no new onset of MDE
(using Diagnostic and Statistical Manual of Mental
Disorders, Fourth Edition, Text Revision (DSM-IV-TR)/
DSM-5 criteria) during the 12-month follow-up.
Assessment will use the web version of the WHO
Composite International Diagnostic Interview V.3.0
depression section.
Ethics and dissemination: The Research Ethics
Review Board of Graduate School of Medicine, the
University of Tokyo (No. 3083-(2)), approved the study
procedures.
Trial registration number: The study protocol is
registered at the UMIN Clinical Trials Registry (UMIN-
CTR; ID=UMIN000014146).
INTRODUCTION
Depressive disorder is one of the most preva-
lent psychiatric disorders, affecting around
340 million people worldwide,1 and it is asso-
ciated with a substantial deterioration in
quality of life and economic loss in the com-
munity and the workplace.2 3 Thus, the
primary prevention of depressive disorder is
an important strategy for global mental
health. In addition, stress has enormous
socioeconomic implications for all spheres of
employment in terms of absenteeism, staff
turnover, lost productivity, poor morale,
etc.4 5 Although the burden of stress and
depression on the workplace is substantial,6
few studies aiming to prevent psychosocial
problems have been conducted.
Two previous meta-analyses have shown
that cognitive behaviour therapy (CBT) is an
effective preventive measure for major
depressive disorder. One meta-analysis
reported that the risk of depressive disorder
decreased by 16% on average in the inter-
vention group and summarised 15 various
types of CBTs.7 Another meta-analysis of ran-
domised controlled trials (RCTs) with a CBT
program, ‘Coping with Depression (CwD)’,8
showed that the program can also prevent
major depressive disorder and indicated a
38% decrease in the risk among participants
in the program.9 However, major limitations
exist in the dissemination of these CBT inter-
ventions: the programs require that profes-
sionals be well trained in CBT;10–12 time, cost
and stigma are other barriers to access to a
CBT program.13
An innovative way to deliver CBT-based treat-
ment widely is by using computerised CBT
(CCBT) and CCBT via the internet (iCBT).
Both CCBT and iCBT programs teach basic
information and skills based on the same CBT
principles as face-to-face CBT programs, with a
highly structured format comprised of
educational lessons, homework assignments
and supplementary resources.14 Previous
studies have shown a signiﬁcant positive treat-
ment effect of CCBT and iCBT programs on
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depression and anxiety in the clinical setting.15 An iCBT
program is particularly beneﬁcial with its high anonymity16
and high accessibility.17 Recently, there have been increas-
ing applications of iCBT for preventing depression. Using
self-reported symptoms of depression as an outcome, one
study of adolescents reported a signiﬁcant prevention
effect of iCBT programs, though it included only male par-
ticipants.18 In addition, one study of university students19
and one community-based study20 reported a signiﬁcant
effect of iCBT programs on improving depressive
symptoms in non-clinical settings. However, one
community-based study failed to show a signiﬁcant
effect.21 We also have reported that a six-session iCBT
program successfully improved symptoms of depression in
an RCT in the workplace.22 However, a search of the litera-
ture revealed only one previous RCT (conducted by the
authors),23 which investigated the effect of an iCBT
program on reducing the risk of major depressive episodes
(MDEs) diagnosed according to the Diagnostic and
Statistical Manual of Mental Disorders (DSM)-IV diagnos-
tic criteria.24 The control group was also provided with a
treatment program during the follow-up.23 Thus, evidence
for the effect of an iCBT on reducing risk of MDE is still
very limited.
A previous follow-up survey of employees in a
company showed that the incidence of DSM-IV major
depressive disorder was 2.8% during 12 months in
Japan.25 If we randomise about 8000 participants equally
to intervention and control groups (4000 in each
group), the total incidence will be 146 (55 and 91 in the
intervention and control groups, respectively), assuming
that incidence ratio (IR)=0.62 (see sample size calcula-
tion in method and analysis for details). Since the
number of participants will be large, it would not be pos-
sible to conduct face-to-face or even telephone inter-
views to ascertain the occurrence of MDE during the
follow-up; it is a feasible strategy to use the web-based
self-report version of a standard structured interview,
such as the WHO-Composite International Diagnostic
Interview (CIDI) V.3.0 depression section,26 27 which has
been shown to have good concordance with the clinical
diagnosis of MDE28 and an acceptable 1-year test-retest
reproducibility.25 While a self-report assessment of MDE
is clearly a major limitation, only such an instrument is
feasible for a large-scale trial to reduce the risk of MDE
diagnosed strictly following DSM-IV/DSM-5 criteria,
which cannot be made by a symptom checklist.
Objectives
The present study is a 12-month follow-up large-scale
RCT. An improved iCBT program, which was based on
the results of the previous study,22 will be used. The pur-
poses of this randomised controlled study are as follows:
(1) to decrease the risk of DSM-IV/DSM-5-deﬁned MDE
through the 12-month follow-up among workers in
Japan; (2) to examine the effects of the iCBT program
on improving the symptoms of depression at 3-month,
6-month and 12-month follow-ups among workers who
have subthreshold depressive symptoms in Japan; (3) to
examine the effects of the iCBT program on improving
work engagement and work performance at 3-month,
6-month and 12-month follow-ups among workers in
Japan; and (4) to examine the cost-effectiveness of the
iCBT program. We expect that: (1) the iCBT program
will reduce the risk of MDE during the 12-month
follow-up; (2) it will improve symptoms of depression at
3-month, 6-month and 12-month follow-ups among
workers who have subthreshold depressive symptoms at
baseline; (3) it will improve work engagement and work
performance at 3-month, 6-month and 12-month follow-
ups; and (4) the program will be cost-effective.
Trial design
The study will be a two-arm, parallel-group, treatment as
usual (TAU)-controlled, non-blinded randomised study.
The allocation ratio of the intervention group to the
control group is 1 to 1. Participants will be randomly
allocated either to the intervention group or to the
control group after they have completed a baseline
online questionnaire survey. Online follow-up surveys
will be conducted 3, 6 and 12 months after the baseline.
The study protocol was registered at the UMIN Clinical
Trials Registry (UMIN-CTR; ID=UMIN000014146). This




Working men and women will be selected according to
the following criteria:
Inclusion criteria
▸ Age 20–60 at study entry.
▸ Currently employed full-time by the business
company.
▸ Can access the internet via a PC at home or at his/
her workplace, since the server software used in this
study allows access only from a PC, but not from
mobile devices such as smartphones.
Exclusion criteria
1. Non-regular or part-time employees.
2. Sick leave for 15 or more days for a physical or
mental condition in the past 3 months.
3. Current treatment for a mental health problem from
a mental health professional.
4. An MDE within the past month as ascertained by the
web version of the Japanese WHO-CIDI V.3.0.
5. A lifetime history of bipolar disorder as ascertained
by the web version of the Japanese WHO-CIDI V.3.0.
Procedure
Figure 1 shows the participant ﬂow chart of this trial.
Our previous RCT reported that 47.5% of employees
who received invitation emails completed a baseline
survey and 10% of them had to be excluded.22 For this
study, the clinical research coordinator (CRC) will send
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out invitations to 20 000 employees, of whom 9000 are
expected to give informed consent, and 8100 are
expected to be eligible. These 8100 will be randomised
either to the intervention group (n=4050) or to the
control group (n=4050). They will be allowed to com-
plete the six lessons within 10 weeks after the baseline
survey. Those in the control group can receive the iCBT
after 12 months. An invitation email to all workers in a
corporate group will direct them to a website that
includes a full explanation of the study. After reading
the explanation of the study on the website, they will be
asked to click on an ‘agree’ button to give their consent
to participate in the study; then they will proceed to the
baseline questionnaire page. If a candidate clicks on a
‘disagree’ button, the website page will close. In order
for the randomisation and start of intervention to be as
close as possible, the CRC will endeavour to randomise
the participants immediately after closing the
application and send an email with the iCBT program
course description as soon as possible. A computer
system for automating the randomisation of candidates
on a ﬁrst-come, ﬁrst-served basis is not available.
Intervention program
The iCBT program called Internet CBT Program: Useful
Mental Health Solutions Series for Business is a 6-week web-
based training course that provides CBT-based stress
management skills.22 This program is structured in six
lessons, with one lesson per week. About 30 min are
needed for each lesson, including the homework. This
program can be used anywhere the internet is available.
One of the unique features of the program is that
training is provided along with a Manga ( Japanese
comic) story of a psychologist and a client to facilitate
the understanding of the participants. Several merits of
using a comic story with Manga characters have been
Figure 1 Participant flow chart.
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acknowledged in research on education in school. First,
it helps motivate participants to stay in the program.29
Second, it facilitates easy learning. A program with text
combined with comic stories is easier for learners to
understand compared with a text-only program.29 30
Third, using a comic story fosters learners’ interest in
the program.30 These merits might be applicable to edu-
cation in the workplace because most Japanese people
of working age are familiar with comics.
The present iCBT program was developed with two
established CBT packages as its basis. One is the cogni-
tive therapy program developed by Beck.31 The other is
the ‘CwD’ program developed by Lewinsohn.8 The CBT
skill components included in the program are: self-
monitoring, cognitive restructuring, assertiveness,
problem-solving and relaxation. The behavioural activa-
tion technique, a main component of the CwD, is not
included in the present RCT in order to be consistent
with the previous RCT.22 23 At the end of each lesson,
participants will be asked to submit homework on a vol-
untary basis, to receive feedback from trained staff
(eg, clinical psychologists) to facilitate their understand-
ing. Feedback will be sent to the participants within
2 days after their submission.
Table 1 shows the contents of the iCBT program. The
program includes self-monitoring skills (in lesson 2), cog-
nitive restructuring skills (in lessons 3 and 4), assertiveness
skills (in lesson 5), problem-solving skills (in lesson 6) and
relaxation skills (in lesson 4). In this study, the cognitive
restructuring method was adopted as the primary and
main cognitive approach, as it had previously been shown
to be effective in reducing depression.32 Assertiveness and
problem-solving training, as well as training in relaxation,
were chosen as supplementary behavioural approaches to
enhance the effect of the program.
Lesson 1: learning about stress
In this lesson, participants learn about a psychological
stress model.33 A guiding character, clinical psychologist
Miss Rino, speaks about the relationship between stressors
and stress reactions. Homework in this lesson includes
respondents self-checking their stressors and stress reac-
tions to help them identify these factors/conditions.
Lesson 2: knack for self-case formulation based on a CB model
In this lesson, participants learn about a cognitive
behavioural (CB) model, especially the ﬁve-part model
(‘ﬁve-part’ refers to ﬁve areas: situation, thoughts, emo-
tions, behaviour and physical feelings)34 and a self-case
formulation based on this model. Case formulation is a
method used to understand the problem of a client.35
Case formulation is necessary for clients to choose an
appropriate approach to change the vicious circles of
these ﬁve areas. Miss Rino introduces a ﬁve-part CB
model using a vignette of a worker with a work-related
problem. Homework in this lesson includes self-
monitoring using the ﬁve-part model.
Lesson 3: try cognitive restructuring part 1
In this lesson, participants learn about Beck’s cognitive
model and the acquired self-monitoring skills based on
this model. The model postulates that an individual’s
mood and behaviour are affected by his/her automatic
thoughts, which are shaped by dysfunctional schemas.36
The cognitive restructuring technique is one of the
standard cognitive approaches of CBT utilised to change
an automatic negative thought into an actual, realistic
and ﬂexible thought.31 Miss Rino gives a lecture on a
cognitive ABC model (Activating/Actual event, Belief,
and Consequence)31 37 38 and on identifying the auto-
matic thoughts that cause a negative mood. Homework
in this lesson includes a self-monitoring exercise of parti-
cipants’ negative mood caused by an automatic thought
in a particular situation selected by the participants.
Lesson 4: try cognitive restructuring, part 2
In this lesson, participants learn cognitive restructuring
skills. Miss Rino teaches participants how to change an
automatic negative thought into an actual thought.
In the latter half of the lesson, participants learn a relax-
ation technique using a breathing method. Relaxation
techniques are often added to the CBT intervention for
workers, and they have shown signiﬁcant effects on
Table 1 Contents of the iCBT program
Lesson
number Title Contents
1 Learning about stress Learning about a psychological stress model modified for this
iCBT program
2 Knack for a self-case formulation based
on a CB model
Learning about a CB model and how to do self-monitoring
based on CBT
3 Try cognitive restructuring, part 1 Learning about cognitive restructuring
4 Try cognitive restructuring, part 2 Learning about cognitive restructuring and relaxation using a
breathing method
5 Knack for communication Learning about active listening and assertiveness
6 How to solve your problem effectively Learning about problem-solving methods
CB, cognitive behavioural; iCBT, internet-based cognitive behavioural therapy.
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improving depression.39 Homework in this lesson
includes an exercise on cognitive restructuring. On the
basis of the homework of lesson 3, participants try to
reconsider the rationale behind the automatic thought,
seek alternative thinking and replace automatic thought
with rational thinking.
Lesson 5: knack for communication
In this lesson, participants learn active listening (AL)
and assertiveness skills. AL is a way of listening and
responding to another person with an aim to improve
mutual understanding.40 It is applied to non-therapeutic
situations as a tool for better communication.
Assertiveness is typically deﬁned as the legitimate and
honest expression of one’s personal rights, feelings,
beliefs and interests without violating or denying the
rights of others.41 42 In order to communicate assertively,
the DESC (Describe, Express, Specify, and Choose or
Consequence) script is used.43 Assertiveness training can
help employees change their job environments by
teaching them to appropriately communicate their con-
cerns to supervisors, coworkers or subordinates.44
Assertiveness training has often been used as a supple-
mental component of stress management interventions
in the workplace.45 In this lesson, Miss Rino also teaches
AL and assertiveness skills based on the DESC script.
Homework in this lesson includes an assertiveness exer-
cise based on the DESC script.
Lesson 6: how to solve your problem effectively
In this lesson, participants learn a problem-solving tech-
nique based on problem-solving therapy. Problem-
solving therapy is a CB intervention that focuses on
training adaptive problem-solving attitudes and skills.46
A rational problem-solving style involves the deliberate
and systematic application of four major problem-solving
skills: (1) problem deﬁnition and formulation, (2) gen-
eration of alternative solutions, (3) decision-making and
(4) solution implementation and veriﬁcation.47
Problem-solving training is often used in stress manage-
ment intervention in the workplace.39 48 In this lesson,
Miss Rino teaches participants how to sort out the
problem and make a list of solutions using problem-
solving methods. Homework in this lesson includes a
problem-solving exercise.
Intervention group
Participants in the intervention group will complete six
weekly lessons and homework within the iCBT program.
They will be allowed to complete the six lessons and
submit their homework within 10 weeks after the baseline
survey. The participants will be reminded by email to com-
plete each lesson and/or submit their homework if they
have not already done so. Reminders will be sent from the
research ofﬁce to the participants every Monday.
Control group
Participants in the control group will be able to use an
internal employee assistance program service, such as
consulting with a physician or a psychologist, and group-
or online education/training programs for promoting
mental health, as a TAU. These programs contained few
descriptions of CBT knowledge and skills.
Outcomes
Table 2 shows an overview of the outcome measures.
The primary outcome measure will be assessed at the
baseline, and at the 6-month and 12-month follow-ups.
All secondary outcomes, except for the time preference,
will be assessed at the baseline, the 3-month follow-up
(end of acute phase treatment), the 6-month follow-up
and the 12-month follow-up. The time preference will
be assessed at the baseline and the 12-month follow-up.
Non-respondents will receive reminder email at least two
times from the research centre for each of the follow-up
surveys, at 3, 6 and 12-months.
Primary outcome
Incidence of MDE
The primary outcome measure is the onset of MDE
during the 12-month follow-up. To collect accurate infor-
mation of the onset of MDE, assessments will be con-
ducted at the 6-month and 12-month follow-ups. The
onset of MDE during the follow-up will be assessed
using the web version of the Japanese WHO-CIDI V.3.0
depression section26 27 according to DSM, Fourth
Edition, Text Revision (DSM-IV-TR) criteria. The
face-to-face version of WHO-CIDI V.3.0 was translated
into Japanese and proved to be valid for diagnosing
MDE.49 The web version asks respondents the same set
of questions and uses the skip logics of the depression
section, and a diagnosis of MDE is automatically pro-
duced by a computer program using an algorithm spe-
ciﬁc to WHO-CIDI V.3.0. The web version has been
shown to have a good concordance with the clinical
diagnosis of MDE28 and to be reliable in a 1-year
test-retest survey.25 While the WHO CIDI V.3.0 was ori-
ginally designed to produce a diagnosis according to
DSM-IV-TR criteria, the instrument can also produce a
diagnosis of MDE based on DSM-5 criteria.50
Since respondents will be asked to report any episode
of MDE, along with the month of onset, at both the
6-month and 12-month follow-ups, there is a possibility
of discrepancy in the reported onset information. In the
case of such discrepancy, the reported onset at the




The Beck Depression Inventory II (BDI-II) is a 21-item
self-report inventory that measures depressive symptoms
such as sadness, pessimism, suicidal thoughts or wishes,
tiredness or fatigue, loss of energy, and loss of pleasure,
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among others.51 52 Each item is scored on a scale
ranging from 0 to 3, with a higher score indicating more
serious depressive symptoms.
Kessler’s Psychological Distress Scale
Psychological distress will be measured by the Japanese
version of Kessler’s Psychological Distress Scale
(K6).53 54 K6 consists of six items assessing the frequency
with which respondents have experienced symptoms of
psychological distress during the past 30 days. The
response options range from 0 (none of the time) to 4
(all of the time). The internal reliability and validity
found in previous studies are acceptable.53
Health and Productivity Questionnaire
The WHO Health and Productivity Questionnaire
(HPQ) is a self-report instrument designed to estimate
the workplace costs of health problems in terms of self-
reported sickness absence (absenteeism) and reduced
job performance (presenteeism).55 Previous studies
have documented signiﬁcant associations (r=0.61–0.87)
of HPQ work hours assessments with payroll records55
and job performance assessments with supervisor ratings
(r=0.52),56 as well as other administrative records (area
under the curve, 0.58–0.72).27 Respondents will be
asked to rate their overall work performance during the
past 4 weeks. The item will be scored on an 11-point
scale ranging from 0 (worst possible performance) to 10
(best possible performance). High scores indicate a
high degree of perceived work performance.
Sick leave days during the past 3 months
Respondents will be asked to report the number of sick
leave days they took during the past 3 month.
Utrecht Work Engagement Scale
Work engagement will be assessed using the short form
of the Japanese version of the Utrecht Work
Engagement Scale (UWES).57 The UWES consists of
three subscales (ie, vigour, dedication, absorption) com-
prising nine items. Items are scored on a seven-point
scale ranging from 0 (never) to 6 (always). Examples of
items are “At my job, I feel strong and vigorous”
(vigour), “I am enthusiastic about my job” (dedication)
and “I am immersed in my work” (absorption). A total
score is calculated from all nine items.
Time preference (time discounting)
Time preference (time discounting) is one’s relative
valuation for having something (eg, money) currently
compared with its valuation at a later date. It may mod-
erate the effect of an iCBT program. Among others,58 in
this study, time preference is assessed by the following
procedure.59 60 The respondents will be asked to choose
between two options, A and B. The respondent receives
1 million yen (around US$12 000) in a month when he/
she chooses option A, while he/she receives a different
amount in 13 months when he/she chooses option
B. This question consists of nine choices (see table 3).
For example, for the sixth choice, the respondents
compare 1 million yen today to 1 020 000 yen (around
US$12 240) in 13 months. In this case, choosing option
B instead of option A is the same as receiving a 2%
annual increase. The questionnaire is shown in table 3,
where the amount received under option A is speciﬁed
as 1 million yen and the imputed interest rate for option
B changes from −5% to over 10%.
Quality of life
Health-related quality of life will be assessed with the
EQ-5D.61 The EQ-5D consists of ﬁve items covering ﬁve
dimensions (mobility, self-care, usual activities, pain/dis-
comfort and anxiety/depression), each of which is rated
as causing ‘no problems’ to ‘unable to’, and a visual ana-
logue scale. It is a widely applied quality of life










The web version of the
Japanese WHO-CIDI
V.3.0 depression section
Duration before the onset of a
major depressive episode
x x x
BDI-II Severity of depression x x x x
K6 Severity of psychological
distress
x x x x
HPQ Work performance x x x x
Sick leave days Sick leave days in the past
3 months
x x x x
UWES Work engagement x x x x
Time preference Time preference x x
EQ-5D Quality of life x x x x
Healthcare use Healthcare use x x x x
BDI-II, Beck Depression Inventory II; HPQ, Health and Work Performance Questionnaire; K6, Kessler Psychological Distress Scale; UWES,
Utrecht Work Engagement Scale.
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A cost-effectiveness analysis will be based on the main
outcome of depression-free years gained. Depression-
free years will be assessed by calculating the difference
in follow-up lengths and the duration of any MDE
(ie, period of time in weeks that a person meets DSM-IV
criteria). In the cost-utility analysis, quality-adjusted life
years (QALYs) will be the clinical end point. QALYs will
be obtained from the EQ-5D.
Costs
Direct medical costs will be estimated from the questions
about healthcare use. Indirect costs stemming from pro-
duction losses due to absenteeism and presenteeism will
be assessed with the WHO HPQ.55
Healthcare use
Respondents will be asked to report on their healthcare
use at any time during the past 3 months as follows:
(1) consultation with a general practitioner (if yes, the
number of times); (2) history and number of hospitalisa-
tions (if yes, the number of days of hospitalisation);
(3) use of medication of any kind; and (4) use of con-
sultation with an industrial physician or the employee
assistance program (if yes, the number of times).
Sample size calculation
A meta-analysis of CBT interventions using the ‘CwD’
program reported that the average effect size (IR) for
prevention of MDE was 0.62 (95% CI 0.43 to 0.91) at
post-test.9 A follow-up survey of employees in a company
showed that the incidence of major depressive disorder
was 2.8% during 12 months.25 We applied a method pro-
posed by Rubinstein et al62 to calculate a minimal sample
size and a statistical power for a proportional hazard
model analysis. Thus, if we equally randomise 8272 to an
intervention group and control group (4136 participants
in each group), we will have 90% power to detect a treat-
ment effect, assuming that IR=0.62. However, these calcu-
lations ignore dropout. We expect that 75% will complete
our 12-month follow-up, resulting in 3102 respondents in
each group at 12 months. In this situation, we will have
80% power to detect the IR of 0.62.
On the other hand, a previous systematic review has
shown that the incidence of major depressive disorder
was greater in participants with subthreshold depressive
symptoms than in participants without subthreshold
depressive symptoms.63 By stratifying participants accord-
ing to K6, we will conduct subgroup analyses targeting
the high-risk group.
Randomisation
Participants who fulﬁl the inclusion criteria will be ran-
domly allocated to intervention or control groups.
Stratiﬁed permuted-block randomisation will be con-
ducted as well. Participants will be stratiﬁed into 16 strata
according to two factors: K6 score (5 or greater or less
than 5) in the baseline survey and the eight workplaces to
which they belong. The intervention effect may vary
according to the severity of psychological distress at base-
line. In addition to the analysis of the whole sample (to
examine the universal intervention effect), we will also
analyse data by a priori-deﬁned subgroups (to examine
the selective intervention effect). A stratiﬁed permuted-
block random table will be generated by an independent
biostatistician. Enrolment will be conducted by a CRC,
and assignment will be conducted by an independent
research assistant. The stratiﬁed permuted-block random
table will be password protected and blinded to the
researcher. Only the research assistant will be able to
access it during the work of random allocation.
Statistical methods
Clinical efficacy
A survival analysis will be conducted to test for the
effectiveness of the intervention by comparing the
survival time not having an MDE between the interven-
tion and control groups. The survival time of each






(annual), % Circle A or B
1 million yen 950 000 yen −5 A B
1 million yen 1 million yen 0 A B
1 million yen 1 001 000 yen 0.10 A B
1 million yen 1 005 000 yen 0.50 A B
1 million yen 1 010 000 yen 1 A B
1 million yen 1 020 000 yen 2 A B
1 million yen 1 060 000 yen 6 A B
1 million yen 1 100 000 yen 10 A B
1 million yen Over 1 100 000 yen Over 10 A B
Suppose you have two mutually exclusive options to receive some money. You may choose option ‘A’ to receive 1 million yen in a month; or
option ‘B’ to receive a different amount in 13 months. Compare the amounts and delay until its receipt in option ‘A’ with option ‘B’ and indicate
which option you would prefer for each pair of all nine choice pairs.
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participant was calculated as months from baseline to
the onset of MDE or the termination of the observation.
The length of follow-up for each participant will be
represented by either the number of months between
the baseline and the onset of MDE or the end of the
12-month follow-up period (6-month follow-up if a
respondent dropped out at the 12-month follow-up),
whichever comes ﬁrst. The cumulative incidence of
MDE at the 6-month and 12-month follow-ups as well as
event-free survivals in every follow-up month will be esti-
mated by the Kaplan-Meier method, and the statistical
signiﬁcance of the difference between the cumulative
proportions of having an MDE at the 6-month and
12-month follow-ups in the intervention and control
groups will be tested. A log-rank test will be conducted
to test the difference in the survival probabilities
between the intervention and control groups. A single
covariate Cox discrete time hazard model will be used to
test the difference and to estimate the HR and the 95%
CIs of having an MDE in the intervention group com-
pared with the control group. The intervention effect
will also be estimated, adjusting for dependent censor-
ing using the inverse probability of censoring weighted
method for conducting a sensitivity analysis.64 A similar
analysis will also be conducted using an alternative case
deﬁnition, such as having a moderate level of depression
(a BDI-II score of 20 or above).
For secondary outcomes (ie, symptoms of depression),
a mixed model for repeated measures conditional
growth model analysis will be conducted using a group
(intervention and control)* time (baseline, 3-month,
6-month and 12-month follow-ups) interaction as an
indicator of intervention effect. An intention-to-treat
analysis will be conducted as well, using the mixed
model for repeated measures conditional growth model
analysis. Effect sizes and 95% CIs will be calculated
using Cohen’s d among those who completed the ques-
tionnaire at baseline and at a follow-up. The values of
0.2, 0.5 and 0.8 are generally interpreted as being sug-
gestive of small, medium and large effects, respectively.65
In addition, the number needed to treat to reduce
depressive symptoms or psychological distress to achieve
improvement from subthreshold depression will be cal-
culated. Referencing the cut-off scores of BDI-II and K6
of previous studies,51 66 all statistical analyses will be con-
ducted using the SPSS Statistics V.21.0.
Subgroup analysis
The effectiveness of the program may differ according to
the initial severity of depression. We will therefore use, as
one stratiﬁcation factor, high/low subthreshold depres-
sion (ie, participants who scored 5 or more in K6) at the
baseline survey and analyse the results according to a
priori-deﬁned subgroups (selective intervention effect).
Economic analysis
In the cost-effectiveness analysis, the incremental cost-
effectiveness ratio (ICER) will be stated as costs per
depression-free months gained, whereas the ICER in the
cost-utility analysis will represent the costs per quality-
adjusted life month gained. Bootstrapping will be used
to test the robustness of the ICERs and to quantify the
uncertainty around the ratios that will be graphically
represented on a cost-effectiveness plane.
Data monitoring
A Data and Safety Monitoring Board (DSMB) will be set
up, including an independent chair and at least two
independent members. The DSMB will meet every
3 months after the ﬁrst client is randomised. The
purpose of the meetings will be to review the report pre-
pared by the CRC. The CRC will prepare DSMB reports
to monitor recruitment progress and data collection
(eg, percentage completing each follow-up).
ETHICS AND DISSEMINATION
Ethical and safety considerations
We have prepared a website that contains a full explan-
ation of the study. Before the baseline survey, participants
will be invited to read the explanation on the website and
asked to click on an ‘agree’ button to show their consent
to participate in the study. They will then proceed to a
baseline questionnaire page. Candidates will be fully
informed that their participation is totally voluntary, that
even after voluntarily participating they can withdraw
from the study without stating the reason, and that
neither participation nor withdrawal will cause any advan-
tage or disadvantage to them. Written consent is not
required by the Ethical Guidelines for Biomedical
Research Involving Human Subjects, Japan; the Research
Ethics Review Board of Graduate School of Medicine/
Faculty of Medicine, the University of Tokyo has approved
this procedure to obtain the participants’ consent.
Data confidentiality
The survey data will be temporarily stored on a server
placed at the Department of Mental Health, Graduate
School of Medicine, the University of Tokyo. After the
survey, the collected data will be moved to a
password-locked stand-alone PC. The collected data will
be stored as linkable anonymising data. The data will be
accessible only by the CRC.
Dissemination of research findings
The main ﬁndings of this study will be disseminated via
publications in peer-reviewed international journals.
Presentations of study ﬁndings will also be offered at
relevant research conferences, and local academic sym-
posia and seminars.
Strengths and limitations
The greatest strength of this study design is its focus on
the effect of the iCBT program on preventing the onset
of MDE using a large-scale RCT design in a healthy
working population. This study is also intended to add
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evidence for the effect of CBT programs on positive
health outcomes (eg, work engagement and work per-
formance) and economic evaluation of iCBT on the
primary prevention strategy among healthy workers.
One of the major weaknesses of this study is that an
MDE will be measured by self-report, which may be
affected by the perception of the participants or by situ-
ational factors at work. The validity of the web-based
CIDI depression section has been established partially
but needs further clariﬁcation and reﬁnement. The
other limitation is that the participants will be recruited
from one corporate group in Japan. Most of them have
their own PCs in their ofﬁces or homes. The participants
may also be assumed to have experience with using a PC
and studying in online programs. Therefore, generalisa-
tion of the ﬁndings to populations that do not share the
characteristics of the participants may be limited.
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